Seminars in Investigative Medicine will return in January with a virtual presentation by Meinrad Busslinger, PhD.
Dr. Busslinger will present “The role of chromatin loop extrusion in generating a diverse antibody repertoire” via Microsoft Teams from 10:00 to 11:00 a.m. on Thursday, January 14.
Dr. Busslinger is a senior scientist and scientific deputy director of the Research Institute of Molecular Pathology in Vienna, Austria. He is a major figure in immunology, renowned for his contributions to understanding the role of transcription factors in B cell differentiation and function.
In the midst of the COVID-19 pandemic, the mechanism by which the antibody repertoire is established, in particular generation of a vaccine-responsive repertoire, is of great interest. Please join us as we learn more about the key elements that determine the quality of our protective antibody shield.
“The pandemic has disrupted our invited speaker seminar series as there is no travel here, to or from our institution,” said Thomas L. Rothstein, MD, PhD, professor and chair of the Department of Investigative Medicine. “We are generally not able to bring outside speakers here from overseas but as all our group activities are conducted by video conference, overseas speakers are now just an internet link away. After a substantial hiatus, we are re-focusing Seminars in Investigative Medicine on speakers from other continents that we normally would not be able to host in-person but can certainly learn from in a virtual format.”
Additionally, the Department of Investigative Medicine will welcome Dr. Simon Fillatreau for Seminars in Investigative Medicine on Thursday, March 25. Dr. Fillatreau’s virtual presentation is scheduled for noon to 1:00 p.m.
Dr. Fillatreau is a professor at the Institut Necker Enfants Malades and the University of Paris. He has studied regulatory B cells that produce cytokines for many years. His most recent work is “Maturation and persistence of the anti-SARS-CoV-2 memory B cell response” which is not yet published.